IHS Chemical Week

People & Business :: M&A

India's foreign investment board clears Mylan's $1.6-billion acquisition of Agila

9:12 AM MDT | August 28, 2013 | Natasha Alperowicz

India’s Foreign Investment Promotion Board (New Delhi) has cleared Mylan's (Canonsburg, PA) proposal to acquire Agila Specialties (Bangalore, India), a subsidiary of pharma firm Strides Arcolab.   Mylan on 27 February announced that it had signed a definitive agreement to acquire Agila, a developer, manufacturer, and marketer of generic injectable products, from Strides for approximately $1.6 billion in cash plus contingent payments of up to $250 million subject to conditions. Mylan says it has obtained $1 billion in committed financing, which...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa